SpringWorks Therapeutics ... (SWTX)
NASDAQ: SWTX
· Real-Time Price · USD
46.99
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM
SpringWorks Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -83.19M | -77.3M | -53.53M | -39.92M | -87.39M | -94.32M | -79.44M | -77.92M | -73.42M | -74.18M | -72.39M | -69.05M | -61.8M | -56.07M | -41.04M | -47.01M | -29.79M |
Depreciation & Amortization | 1.1M | 1.02M | 878K | 844K | 729K | 538K | 494K | 382K | 253K | 255K | 212K | 190K | 108K | 146K | 119K | 115K | 110K |
Stock-Based Compensation | 29.95M | 26.47M | 25.96M | 26.25M | 30.46M | 25.07M | 23.1M | 22.97M | 23.39M | 18.92M | 18.52M | 18.43M | 17.09M | 11.88M | 10.71M | 8.79M | 7.05M |
Other Working Capital | n/a | 29.65M | 64.34M | -31.92M | -12.06M | 10.67M | 1.35M | 9.49M | 753K | -3.17M | 29.89M | 10.15M | -2.93M | -3.75M | 4.18M | 2.49M | 121K |
Other Non-Cash Items | n/a | 1.65M | -54.03M | 2.22M | 45.44M | 477K | 439K | 451K | 1.56M | 966K | 1.77M | 674K | 609K | 248K | 243K | 245K | 257K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 1.83M | 1.02M | 901K | n/a | n/a | n/a | n/a | n/a | 301K | 267K | 159K | 261K |
Change in Working Capital | n/a | 18.66M | 55.34M | -31.18M | -24.16M | 3.7M | 3.92M | 5.41M | -13.61M | -167K | 32.28M | 10.69M | -4.7M | -2.82M | 2.77M | 4.17M | 1M |
Operating Cash Flow | -68.76M | -29.5M | -25.38M | -41.79M | -78.93M | -62.7M | -50.46M | -47.81M | -61.82M | -54.2M | -19.6M | -39.07M | -48.69M | -46.32M | -26.93M | -33.53M | -21.1M |
Capital Expenditures | -30K | -6.05M | 9.4M | -12.22M | -577K | 2.3M | -3.62M | -3.09M | -2.98M | -1.76M | -3.53M | -2.52M | -2.39M | -1.5M | -335K | -132K | -45K |
Cash Acquisitions | n/a | n/a | 8.23M | n/a | -8.23M | -2.3M | 3.62M | 3.09M | -2.8M | 10.2M | n/a | -4.2M | n/a | 1.5M | 335K | 132K | 45K |
Purchase of Investments | n/a | -80.84M | -36.79M | -85.59M | -81.88M | -266.45M | -96.66M | -144.46M | -68.15M | -413.1M | n/a | -44.71M | -23.24M | -86.56M | -77.97M | -54.52M | -86.37M |
Sales Maturities Of Investments | 73.42M | 101.04M | 75.52M | 98.1M | 103.92M | 104.94M | 134.88M | 208.31M | 172.53M | 59.84M | 89.76M | 78.19M | 52.05M | 144.25M | 114.09M | 77.2M | 55.5M |
Other Investing Acitivies | n/a | n/a | -27.72M | n/a | -8.23M | 2.3M | -3.62M | -3.09M | 101.58M | -10.2M | 89.76M | 29.28M | 28.81M | -1.5M | -335K | -132K | -45K |
Investing Cash Flow | 73.39M | 14.14M | 28.65M | 289K | 21.46M | -159.21M | 34.6M | 60.76M | 98.6M | -355.01M | 86.23M | 26.76M | 26.42M | 56.18M | 35.78M | 22.54M | -30.92M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -523K | -499K | -919K | -6.5M | -253K | -264K | -352K | -1.93M | 1.34M | -212K | -223K | -906K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -10.61M | 1.18M | 1.79M | 4.29M | 5.95M | 24K | 22K | 10K | 83K | 298K | 377K | 135K | 1.17M | 244K | 425K | 129K | 359K |
Financial Cash Flow | -10.61M | 653K | 1.29M | 3.37M | -552K | 299.07M | -242K | -342K | -1.85M | 298K | 340.23M | -88K | 261K | 244K | 425K | 129K | 359K |
Net Cash Flow | -5.97M | -14.7M | 5.18M | -38.13M | -58.02M | 77.16M | -16.1M | 12.6M | 34.94M | -408.91M | 406.86M | -12.4M | -22M | 10.11M | 9.28M | -10.86M | -51.66M |
Free Cash Flow | -68.79M | -35.55M | -15.98M | -54.02M | -79.51M | -60.4M | -54.08M | -50.9M | -64.8M | -55.96M | -23.13M | -41.6M | -51.08M | -47.82M | -27.26M | -33.66M | -21.15M |